
- Usually lifelong
- Permanent testicular or pituitary causes
- Often reversible
- Obesity, sleep apnea, opioids, alcohol
- After stopping
- Recovery can take months
- Fertility
- TRT suppresses sperm production
Two very different kinds of low testosterone
Some men have what is called organic hypogonadism: the testes have been damaged or the pituitary gland cannot send the right signals, because of a genetic condition, injury, surgery, chemotherapy, a pituitary tumor or similar causes. These problems do not usually resolve, so replacement is generally long-term.
Many midlife men have a different pattern, often called functional hypogonadism. The hormone system is structurally intact but suppressed by something else. A 2017 review in the Journal of Clinical Endocrinology & Metabolism described obesity as the strongest risk factor and noted that weight loss can raise testosterone, with larger losses producing larger increases.
Common reversible contributors
Guidelines from the American Urological Association call for checking LH, and prolactin when LH is low or normal, partly to help identify these causes. Your clinician will usually look for them before or alongside starting therapy.
- Excess body fat, especially around the abdomen
- Obstructive sleep apnea and chronically short sleep
- Opioid pain medicines and some other medications
- Heavy alcohol use
- Poorly controlled diabetes or other chronic illness
- A high prolactin level
- Severe stress, overtraining or very low calorie intake
Why stopping is not like stopping a vitamin
Testosterone from outside the body tells your brain there is plenty of hormone, so it turns down LH and FSH, the signals that drive your testes. Over time, your own production and sperm output fall. When you stop, those signals have to restart, and for a while you may have less testosterone than before you began.
That dip can bring back fatigue, low libido and low mood, sometimes more noticeably than before treatment. Recovery commonly happens, but its speed varies, and longer use and older age can make it slower or less complete. Sperm production may take many months to return, and the AUA advises against testosterone for men trying to conceive.
What staying on long-term involves
Long-term therapy is a commitment to monitoring as well as medication. Your clinician will periodically check testosterone levels, hematocrit, PSA in men over 40, blood pressure and how you feel. FDA added a blood pressure warning to all testosterone product labels in 2025.
The AUA also recommends discussing stopping three to six months after starting if your testosterone normalizes but your symptoms do not improve. Treatment that is not helping is not worth continuing.
Getting the diagnosis right at the start
The question of whether you will need therapy forever is easiest to answer when the diagnosis was solid in the first place. Guidelines call for symptoms plus at least two low morning testosterone results on separate days. Testosterone naturally varies through the day and can dip during illness, poor sleep or calorie restriction, so a single low reading can mislead.
LH and FSH help show where the problem lies. High LH with low testosterone points to the testes, which is less likely to reverse. Low or normal LH points to the brain's signaling, which is where most reversible causes act. Knowing which pattern you have shapes the long-term plan.
When it is worth revisiting
If one of these applies, talk with your clinician rather than stopping abruptly. A plan might involve tapering, rechecking labs after a set period or, for men focused on fertility, considering other approaches.
- Your symptoms never really improved, even with levels in range
- You have since lost significant weight, treated sleep apnea or stopped opioids
- You now want to have children
- Side effects such as a rising hematocrit are hard to manage
- The original diagnosis rested on a single test or borderline numbers
Alternatives for men who want to keep their own production
For men whose testes still work but are under-stimulated, medicines that raise LH and FSH can lift testosterone without shutting down sperm production. The AUA guideline notes that clinicians may use selective estrogen receptor modulators, hCG or aromatase inhibitors in men who want to preserve fertility.
HealifyMD offers testosterone replacement therapy at $249 for the first month (including the lab panel), then $149/month. The Enclomiphene / DHEA / Boron / Pregnenolone ODT, a compounded product that is not FDA-approved, is from $129/month. Other labs are priced separately, and your price is confirmed at the eligibility review.
Common questions
Can I take a break from TRT?
You can, but your own production may take months to restart, and symptoms often return in the meantime. Plan any break with your clinician.
Will my testosterone return to normal after stopping?
Many men recover their natural production, but how fast and how fully varies. Longer use and older age can slow recovery.
How do I know if my low T is reversible?
Your clinician looks at LH, FSH, prolactin, weight, sleep, medications and alcohol use. Improving a contributing factor and rechecking is often the clearest test.
Does losing weight raise testosterone?
Often, yes. Research shows weight loss can raise testosterone in men with obesity, with bigger losses producing bigger increases.
Should I stop TRT if I want children?
Testosterone therapy suppresses sperm production, so talk with your clinician early. Options that support your own production may be more suitable.
What happens if I stop suddenly?
Levels can drop below your pre-treatment baseline for a while, which may bring back fatigue, low libido or low mood. A planned approach is safer.
Is long-term TRT safe?
Large trials have been reassuring on heart events in men with confirmed deficiency, but long-term use still requires regular monitoring of blood counts, PSA and blood pressure.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- Evaluation and Management of Testosterone Deficiency (guideline)American Urological Association
- Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline (2018)Endocrine Society (Journal of Clinical Endocrinology & Metabolism)
- A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017)Journal of Clinical Endocrinology & Metabolism
- FDA Issues Class-Wide Labeling Changes for Testosterone ProductsU.S. Food and Drug Administration
- Testosterone InjectionMedlinePlus (National Library of Medicine)